Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UL0R
|
|||
| Former ID |
DIB006440
|
|||
| Drug Name |
BK-C-0701
|
|||
| Indication | Diabetic neuropathy [ICD-11: 8C0Z; ICD-10: G63, G63.2] | Phase 3 | [1] | |
| Company |
Bukwang Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01261143) Randomized, Double-blind Study to Assess the Efficacy and Safety of alpha-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.